Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
This invention is related to pharmaceutical compositions of rosuvastatin or pharmaceutically acceptable sails thereof especially calcium salt with sodium carbonate anhydrous which has effects on dissolution profiles in 0.1 N HCl medium provided that using of sodium carbonate anhydrous should be presence in the range of from about 0.5 % to about 2 % by weight.
UAA201100796A2008-06-272008-06-27Pharmaceutical compositions of rosuvastatin calcium
UA99199C2
(en)